Souhaitez-vous accéder aux communiqués récents ?

Ad-hoc-Mitteilung gemäss Artikel 53 des Kotierungsreglements der SIX Swiss Exchange AG Männedorf, Schweiz, 10. Juli, 2025 – Die Tecan Group (SIX Swiss Exchange: TECN) gab heute einen geplanten...

Ad hoc announcement pursuant to Article 53 of the SIX Exchange Regulation Listing Rules Männedorf, Switzerland, July 10, 2025 – The Tecan Group (SIX Swiss Exchange: TECN) today announced a planned...

New product offers regulated access to one of the most promising blockchain networks in global trade finance Zurich, 9 July 2025 – 21Shares, one of the world’s leading issuers of cryptocurrency...

Response welcomes progress but calls for more inclusive, globally aligned framework London, 8 July 2025 – 21Shares, one of the world’s leading issuers of crypto exchange-traded products (ETPs), has...

Ad hoc-Mitteilung gemäss Art. 53 KR Allschwil, 08. Juli 2025 Basilea Pharmaceutica AG, Allschwil (SIX: BSLN), ein biopharmazeutisches Unternehmen mit bereits vermarkteten Produkten und...

Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, July 08, 2025 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to...

Coartem® (artemether-lumefantrine) Baby becomes first malaria treatment approved for newborn babies and young infants Rapid approvals in eight African countries now expected under a special global...

INVITATION TO THE MEDIA & ANALYST WEBCAST July 25, 2025, 11:00 a.m. Half year results 2025 and outlook Steinhausen, July 4, 2025 – We cordially invite you to the media, analyst and investor...

The GCAptAIN study did not meet its primary endpoint of sustained remission at Week 52 in adults with newly diagnosed or relapsing GCA1Safety in GCA patients was consistent with known safety profile...

MEDIA RELEASE Investment marks latest step in strategic plan to capture significant part of unprecedented biosimilar patent-expiry market opportunity of USD 222 billion over next 10 yearsOngoing...